**CORAL GABLES, Fla.** — **November 18, 2025** — Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX) will participate in Citi’s 2025 Global Healthcare Conference in Miami on Tuesday, December 2, 2025, the company announced today.
Rich Daly, President and CEO, along with other members of Catalyst’s management team, will be in attendance. The presentation is scheduled for Tuesday, December 2, 2025, at 1:00 p.m. ET.
A live webcast of the presentation will be accessible via the Investors section of Catalyst’s website, and a replay will be available for at least 30 days following the event.
Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases. Recognized on the Forbes 2025 list as one of America’s Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America’s Fastest-Growing Companies, Catalyst maintains a U.S. presence while exploring strategic opportunities for global expansion.
Investor Contact:
Melissa Kendis
Catalyst Pharmaceuticals, Inc.
(305) 420-3200
IR@catalystpharma.com
Media Contact:
David Schull or Olipriya Das
Russo Partners
(858) 717-2310, (646) 942-5588
david.schull@russopartnersllc.com, Olipriya.das@russopartnersllc.com
Source: Catalyst Pharmaceuticals, Inc.
